文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

OGT 通过将 MORC2 丝氨酸 556 进行 O-GlcNAc 酰化,将 TGF-β 信号与乳腺癌进展偶联。

O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression.

机构信息

Fudan University Shanghai Cancer Center and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.

Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

出版信息

Cell Death Differ. 2022 Apr;29(4):861-873. doi: 10.1038/s41418-021-00901-0. Epub 2022 Jan 1.


DOI:10.1038/s41418-021-00901-0
PMID:34974534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8991186/
Abstract

MORC family CW-type zinc finger 2 (MORC2) is a newly identified chromatin-remodeling enzyme involved in DNA damage response and gene transcription, and its dysregulation has been linked with Charcot-Marie-Tooth disease, neurodevelopmental disorder, and cancer. Despite its functional importance, how MORC2 is regulated remains enigmatic. Here, we report that MORC2 is O-GlcNAcylated by O-GlcNAc transferase (OGT) at threonine 556. Mutation of this site or pharmacological inhibition of OGT impairs MORC2-mediated breast cancer cell migration and invasion in vitro and lung colonization in vivo. Moreover, transforming growth factor-β1 (TGF-β1) induces MORC2 O-GlcNAcylation through enhancing the stability of glutamine-fructose-6-phosphate aminotransferase (GFAT), the rate-limiting enzyme for producing the sugar donor for OGT. O-GlcNAcylated MORC2 is required for transcriptional activation of TGF-β1 target genes connective tissue growth factor (CTGF) and snail family transcriptional repressor 1 (SNAIL). In support of these observations, knockdown of GFAT, SNAIL or CTGF compromises TGF-β1-induced, MORC2 O-GlcNAcylation-mediated breast cancer cell migration and invasion. Clinically, high expression of OGT, MORC2, SNAIL, and CTGF in breast tumors is associated with poor patient prognosis. Collectively, these findings uncover a previously unrecognized mechanistic role for MORC2 O-GlcNAcylation in breast cancer progression and provide evidence for targeting MORC2-dependent breast cancer through blocking its O-GlcNAcylation.

摘要

MORC 家族 CW 型锌指 2(MORC2)是一种新发现的参与 DNA 损伤反应和基因转录的染色质重塑酶,其功能失调与 Charcot-Marie-Tooth 病、神经发育障碍和癌症有关。尽管它具有重要的功能,但 MORC2 的调控机制仍不清楚。在这里,我们报告 MORC2 可被 O-连接的 N-乙酰葡糖胺转移酶(OGT)在苏氨酸 556 位进行 O-连接的 N-乙酰葡糖胺化。该位点的突变或 OGT 的药理学抑制会损害 MORC2 介导的体外乳腺癌细胞迁移和侵袭以及体内肺定植。此外,转化生长因子-β1(TGF-β1)通过增强限速酶谷氨酰胺-果糖-6-磷酸氨基转移酶(GFAT)的稳定性来诱导 MORC2 的 O-连接的 N-乙酰葡糖胺化,GFAT 是产生 OGT 糖供体的酶。O-连接的 N-乙酰葡糖胺化的 MORC2 是 TGF-β1 靶基因结缔组织生长因子(CTGF)和蜗牛家族转录抑制因子 1(SNAIL)转录激活所必需的。这些观察结果得到了支持,敲低 GFAT、SNAIL 或 CTGF 会损害 TGF-β1 诱导的、MORC2 O-连接的 N-乙酰葡糖胺化介导的乳腺癌细胞迁移和侵袭。临床上,乳腺癌肿瘤中 OGT、MORC2、SNAIL 和 CTGF 的高表达与患者预后不良有关。总的来说,这些发现揭示了 MORC2 O-连接的 N-乙酰葡糖胺化在乳腺癌进展中的一个以前未被认识的机制作用,并为通过阻断其 O-连接的 N-乙酰葡糖胺化来靶向依赖 MORC2 的乳腺癌提供了证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/ef4f2fff7c78/41418_2021_901_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/a65ff21e2585/41418_2021_901_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/713d1596b541/41418_2021_901_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/fcf0ff1743fb/41418_2021_901_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/0db533fbad8d/41418_2021_901_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/e97b9d25a7db/41418_2021_901_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/a4f95b6ff5ed/41418_2021_901_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/ef4f2fff7c78/41418_2021_901_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/a65ff21e2585/41418_2021_901_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/713d1596b541/41418_2021_901_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/fcf0ff1743fb/41418_2021_901_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/0db533fbad8d/41418_2021_901_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/e97b9d25a7db/41418_2021_901_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/a4f95b6ff5ed/41418_2021_901_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6af3/8991186/ef4f2fff7c78/41418_2021_901_Fig7_HTML.jpg

相似文献

[1]
O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression.

Cell Death Differ. 2022-4

[2]
mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.

Mol Cancer Res. 2015-5

[3]
Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer.

Theranostics. 2023

[4]
Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.

Oncol Rep. 2018-8-1

[5]
-GlcNAcylation regulates integrin-mediated cell adhesion and migration via formation of focal adhesion complexes.

J Biol Chem. 2018-12-26

[6]
Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.

Autophagy. 2020-6

[7]
O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.

J Cell Mol Med. 2019-1-24

[8]
Histone methyltransferase Dot1L recruits O-GlcNAc transferase to target chromatin sites to regulate histone O-GlcNAcylation.

J Biol Chem. 2022-7

[9]
Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.

J Biol Chem. 2012-1-24

[10]
Chromatin remodeling protein MORC2 promotes breast cancer invasion and metastasis through a PRD domain-mediated interaction with CTNND1.

Oncotarget. 2017-6-16

引用本文的文献

[1]
Necroptosis in cancer: insight from epigenetic, post-transcriptional and post-translational modifications.

J Hematol Oncol. 2025-7-30

[2]
Multi-transcriptomics predicts clinical outcome in systemically untreated breast cancer patients with extensive follow-up.

Breast Cancer Res. 2025-7-15

[3]
Post-translational modifications of cancer immune checkpoints: mechanisms and therapeutic strategies.

Mol Cancer. 2025-7-8

[4]
A Self-Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple-Negative Breast Cancer Therapy.

Adv Sci (Weinh). 2025-6

[5]
Expression significance of biomarker MORC4 in colorectal cancer patients and its relationship with pathological features and prognosis.

World J Gastrointest Oncol. 2025-3-15

[6]
FBXO31-mediated ubiquitination of OGT maintains O-GlcNAcylation homeostasis to restrain endometrial malignancy.

Nat Commun. 2025-2-2

[7]
O-GlcNAcylation-related genes mediate tumor microenvironment characteristics and prediction of immunotherapy response in gastric cancer.

Acta Biochim Biophys Sin (Shanghai). 2024-12-12

[8]
JUNB O-GlcNAcylation-Mediated Promoter Accessibility of Metabolic Genes Modulates Distinct Epithelial Lineage in Pulmonary Fibrosis.

Adv Sci (Weinh). 2025-2

[9]
Biological functions and molecular mechanisms of MORC2 in human diseases.

Mol Cells. 2025-1

[10]
Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance.

Exp Hematol Oncol. 2024-11-1

本文引用的文献

[1]
Role of -Linked -Acetylglucosamine Protein Modification in Cellular (Patho)Physiology.

Physiol Rev. 2021-4-1

[2]
De Novo Variants in the ATPase Module of MORC2 Cause a Neurodevelopmental Disorder with Growth Retardation and Variable Craniofacial Dysmorphism.

Am J Hum Genet. 2020-7-20

[3]
Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.

Autophagy. 2020-6

[4]
Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer.

Nucleic Acids Res. 2020-4-17

[5]
Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer.

Theranostics. 2020

[6]
Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress.

Biochemistry. 2020-9-1

[7]
MORC2 regulates DNA damage response through a PARP1-dependent pathway.

Nucleic Acids Res. 2019-9-19

[8]
Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy.

J Clin Invest. 2020-1-2

[9]
O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability.

Theranostics. 2019-5-24

[10]
Elevation of O-GlcNAc and GFAT expression by nicotine exposure promotes epithelial-mesenchymal transition and invasion in breast cancer cells.

Cell Death Dis. 2019-4-24

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索